在K176的Runx2由4-Hydroxynonenal加快血管化
Xiaoxuan Zhai1,2,3, Shengchuan Cao1,2,3, Jiali Wang1,2,3,4
1Department of Emergency and Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China (X.Z., S.C., J.W., B.Q., X.L., R.H., M.Z., S.S., Y.H., S.W., J.P., Q.Y., F.X., S.W., Y.C.).
Circulation
|February 13, 2024
概括
通过稳定Runx2促进了血管化. 阿尔德脱酶2 (ALDH2) 保护这种过程,这表明ALDH2是血管化的治疗点.
科学领域:
- 生物化学
- 心血管生物学
- 分子医学
背景情况:
- 血管化涉及复杂的调节机制,与心血管不良事件有关.
- 脂质过氧化产物4-诺纳尔 (4-HNE) 在血管化中的作用尚不清楚.
研究的目的:
- 研究4-HNE在血管化的作用.
- 探索脱酶2 (ALDH2) 在这个过程中的参与.
- 确定血管化的潜在治疗点.
主要方法:
- 在慢性病患者和对照患者中测量4-HNE水平.
- 在冠状动脉斑块中分析沉积和4-HNE.
- 在患者中评估了冠状动脉化与ALDH2 rs671突变之间的关联.
- 使用ALDH2淘汰和转基因小鼠模型研究血管化.
- 在培养的大动脉光滑肌细胞中研究细胞化和分子机制.
主要成果:
- 在患有慢性病的患者和化动脉中发现了高水平的4-HNE.
- 缺少ALDH2加速了血管化,而ALDH2过度表达/激活则阻止了这种情况.
- 患有ALDH2rs671突变的患者表现出更严重的冠状动脉化.
- 通过增加Runx2水平,4-HNE在体外促进了血管光滑肌肉细胞的化.
- 在K176中直接碳化Runx2,增强其稳定性并促进化.
结论:
- 4-HNE通过直接碳化和稳定Runx2促进血管化.
- ALDH2对血管化起着保护作用.
- ALDH2是治疗血管化的潜在治疗点.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K


